Bottom line
How much do PRHSX and ETHSX overlap?
64% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.2% of PRHSX's assets and 57.9% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and ETHSX have in common
| Holding | % of PRHSX | % of ETHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 12.47% | 12.47% |
| Johnson & Johnson | 6.63% | 6.45% | 6.45% |
| Unitedhealth Group Inc | 5.99% | 5.49% | 5.49% |
| Abbvie Inc | 5.10% | 6.46% | 5.10% |
| Merck & Co. Inc. | 4.01% | 5.08% | 4.01% |
| Gilead Sciences Inc | 2.82% | 3.34% | 2.82% |
| Thermo Fisher Scientific Inc | 2.52% | 2.79% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.28% | 3.38% | 2.28% |
| Bristol-myers Squibb Co | 2.11% | 4.25% | 2.11% |
| Abbott Laboratories | 1.89% | 1.65% | 1.65% |
| Intuitive Surgical Inc | 1.87% | 2.72% | 1.87% |
| Stryker Corp | 1.78% | 2.21% | 1.78% |
| Royalty Pharma Plc- Cl A | 0.97% | 1.58% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Amgen Inc — 1.82%
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Danaher Corp — 1.43%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Cvs Health Corp — 0.94%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Only in ETHSX
- AstraZeneca PLC — 6.24%
- Roche Holding AG — 5.44%
- Sanofi SA — 2.95%
- Boston Scientific Corp — 2.18%
- Medtronic PLC — 1.80%
- Lonza Group AG — 1.77%
- Novo Nordisk A/S — 1.71%
- Novartis AG — 1.65%
- Argenx SE — 1.61%
- Neurocrine Biosciences Inc — 1.41%
- Mettler-Toledo International Inc — 1.36%
- Straumann Holding AG — 1.34%
Asset mix
| Asset type | PRHSX | ETHSX |
|---|---|---|
| Stocks | 96.4% | 99.4% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 0.7% | 0.3% |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | PRHSX | ETHSX |
|---|---|---|
| US | 92.6% | 69.4% |
| CH | 0.5% | 10.2% |
| GB | 1.7% | 7.8% |
| FR | 0.2% | 3.2% |
| DK | 0.7% | 2.9% |
| NL | 1.0% | 2.0% |
| IE | 0.8% | 1.8% |
| AU | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PRHSX and ETHSX overlap?
What stocks do PRHSX and ETHSX have in common?
Should I own both PRHSX and ETHSX?
Which holds more stocks, PRHSX or ETHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.